Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Vaxxinity stock (VAXX)

Buy Vaxxinity stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Vaxxinity is a biotechnology business based in the US. Vaxxinity shares (VAXX) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.01 – an increase of 9900% over the previous week. Vaxxinity employs 57 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Vaxxinity stock

Top pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you open and fund a new account within 30 days
  • Access to a financial planner
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.

Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers

Top pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Get 4% annual equivalent rate on your cash
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Best for social investing

Go to site
  • Trade stocks, options and ETFs without commissions and no options contract fees
  • Earn 3.9% annual interest on options balances
  • Copy top crypto investors with eToro's innovative CopyTrader
  • Trade leading cryptocurrencies including BTC and ETH

How to buy Vaxxinity stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – VAXX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Vaxxinity stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
7 of 7
Product Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.01%
Get up to $1,000 in stock
Trade stocks, ETFs, and options with zero commissions, invest in IPOs or automate your portfolio, with exclusive perks available through SoFi Plus.
Finder score
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex, Treasury Bills, Precious metals
$0
$0
3.83% Lite
4.83% Pro
N/A
Trade a wide range of assets, with global market access and pro-grade trading tools.
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Event contracts, High-yield cash account
$0
$0
4%
Get a free stock
Trade stocks, options, crypto and more, with advanced trading tools, fractional shares and exclusive perks for Gold members.
OPTO logo
Finder score
Finder score
Stocks, ETFs
$0
$0
4%
Earn up to $300
Copy top-performing portfolios or build your own stock index on Opto's AI-driven thematic investing platform, and get 4% APY on your cash.
eToro logo
Finder score
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Investments
$0
$0
3.9%
N/A
No commission stock, ETF and options trades, with 3.9% interest on your options account balance and no options contract fees. See full disclosure.
Frec logo
Finder score
Finder score
Stocks, ETFs
$0
$20,000
4.03%
N/A
Low-cost direct indexing. Plus, trade individual stocks and earn up to 5% yield with a Frec Treasury account.
Acorns logo
Finder score
Finder score
Stocks, ETFs
$0
$0
N/A
Get a $20 bonus
Automate investing with recurring contributions starting at $5 and invest spare change from everyday purchases.
loading
Showing 7 of 7 results

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Vaxxinity stock price (PINK: VAXX)

Use our graph to track the performance of VAXX stocks over time.

Vaxxinity shares at a glance

Information last updated 2025-07-23.
Latest market close$0.01
52-week range$0.00 - $0.30
50-day moving average $0.01
200-day moving average $0.01
Wall St. target price$15.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.45

Vaxxinity price performance over time

Historical closes compared with the close of $0.044 from 2025-07-24

1 week (2025-07-18) 43,900.00%
1 month (2025-06-26) -2.22%
3 months (2025-04-25) 21,900.00%
6 months (2025-01-24) 10,900.00%
1 year (2024-07-26) 46.67%
2 years (2023-07-26) -98.30%
3 years (2022-07-26) 1.7
5 years (2020-07-22) N/A

Vaxxinity financials

Gross profit TTM $-1,871,000
Return on assets TTM -48.34%
Return on equity TTM -150.65%
Profit margin 0%
Book value $0.11
Market Capitalization $12,678

TTM: trailing 12 months

Vaxxinity share dividends

We're not expecting Vaxxinity to pay a dividend over the next 12 months.

You may also wish to consider:

Vaxxinity share price volatility

Over the last 12 months, Vaxxinity's shares have ranged in value from as little as $0.0001 up to $0.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Vaxxinity's is -23.876. This would suggest that Vaxxinity's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Vaxxinity has bucked the trend.

To put Vaxxinity's beta into context you can compare it against those of similar companies.

Vaxxinity overview

Vaxxinity, Inc. , a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313, which is in Phase 1 clinical trial targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. It has a collaboration agreement with the University of Florida, University of Central Florida, and the University of Southampton. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida. .

Frequently asked questions

What percentage of Vaxxinity is owned by insiders or institutions?
Currently 50.707% of Vaxxinity shares are held by insiders and 0.021% by institutions.
How many people work for Vaxxinity?
Latest data suggests 57 work at Vaxxinity.
When does the fiscal year end for Vaxxinity?
Vaxxinity's fiscal year ends in December.
Where is Vaxxinity based?
Vaxxinity's address is: 505 Odyssey Way, Merritt Island, FL, United States, 32953
What is Vaxxinity's ISIN number?
Vaxxinity's international securities identification number is: US92244V1044
What is Vaxxinity's CUSIP number?
Vaxxinity's Committee on Uniform Securities Identification Procedures number is: 92244V104

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site